Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ
Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ
Recruiting · NCT06761846 · Registry updated 2026-04-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ | gastric adenocarcinoma, gastroesophageal junction adenocarcinoma | Recruiting | Phase 2 | 2026-04-21 | NCT06761846 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 294 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hodpital, Chinese Academy of Medical Sciences and Peking Union Medical College | Beijing | China | 2 |